Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carfilzomib, Thalidomide and Dexamethasone in RRMM
NCT03140943Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Sep 2017
- Primary completion
- Jun 2019
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 4
01
Overview
A Phase 2 trial of carfilzomib in multiple myeloma (MM), sponsored by National University Hospital. Status: unknown.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03140943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03140943.